Table of Content

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of End-Use
  • 1.1.4 Scope of Product Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

Fig Global Hyperimmune Globulins Market Size and CAGR 2015-2019 (Million USD)

Fig Global Hyperimmune Globulins Market Size and CAGR 2015-2019 (Volume)

Fig Global Hyperimmune Globulins Market Forecast and CAGR 2020-2025 (Million USD)

Fig Global Hyperimmune Globulins Market Forecast and CAGR 2020-2025 (Volume)

2 Regional Market

• 2.1 Regional Sales

Tab Regional Sales Revenue 2015-2019 (Million USD)

Tab Regional Sales Volume 2015-2019 (Volume)

• 2.2 Regional Demand

Tab Regional Demand and CAGR List 2015-2019 (Million USD)

Tab Regional Demand and CAGR List 2015-2019 (Volume)

Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)

• 2.3 Regional Trade

Tab Regional Export 2015-2019 (Million USD)

Tab Regional Export 2015-2019 (Volume)

Tab Regional Import 2015-2019 (Million USD)

Tab Regional Import 2015-2019 (Volume)

3 Key Manufacturers

• 3.1 CSL Behring
  • 3.1.1 Company Information

Tab Company Profile List of CSL Behring

• 3.1.2 Product & Services
• 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CSL Behring

• 3.1.4 Recent Development

Tab Company Profile List of Grifols

• 3.2.2 Product & Services
• 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Grifols

• 3.2.4 Recent Development

Tab Company Profile List of Biotest

• 3.3.2 Product & Services
• 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Biotest

• 3.3.4 Recent Development

Tab Company Profile List of Kedrion

• 3.4.2 Product & Services
• 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kedrion

• 3.4.4 Recent Development

Tab Company Profile List of CBPO

• 3.5.2 Product & Services
• 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CBPO

• 3.5.4 Recent Development

Tab Company Profile List of Emergent (Cangene)

• 3.6.2 Product & Services
• 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Emergent (Cangene)

• 3.6.4 Recent Development

Tab Company Profile List of Kamada

• 3.7.2 Product & Services
• 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Kamada

• 3.7.4 Recent Development

Tab Company Profile List of CNBG

• 3.8.2 Product & Services
• 3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of CNBG

• 3.8.4 Recent Development

Tab Company Profile List of Hualan Bio

• 3.9.2 Product & Services
• 3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Hualan Bio

• 3.9.4 Recent Development

Tab Company Profile List of Shanghai RAAS

• 3.10.2 Product & Services
• 3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Shanghai RAAS

• 3.10.4 Recent Development

Tab Company Profile List of Sichuan Yuanda Shuyang

• 3.11.2 Product & Services
• 3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sichuan Yuanda Shuyang

• 3.12 ADMA Biologics
  • 3.12.1 Company Information

Tab Company Profile List of ADMA Biologics

• 3.12.2 Product & Services
• 3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

Tab Sales Revenue, Sales Volume, Price, Cost and Margin of ADMA Biologics

4 Major End-Use

• 4.1 Government Institutions
  • 4.1.1 Overview

Tab Summary of Consumption Distribution of Government Institutions

• 4.1.2 Government Institutions Market Size and Forecast

Fig Government Institutions Market Size and CAGR 2015-2019 (Million USD)

Fig Government Institutions Market Size and CAGR 2015-2019 (Volume)

Fig Government Institutions Market Forecast and CAGR 2020-2025 (Million USD)

Fig Government Institutions Market Forecast and CAGR 2020-2025 (Volume)

• 4.2 Private Sector
  • 4.2.1 Overview

Tab Summary of Consumption Distribution of Private Sector

• 4.2.2 Private Sector Market Size and Forecast

Fig Private Sector Market Size and CAGR 2015-2019 (Million USD)

Fig Private Sector Market Size and CAGR 2015-2019 (Volume)

Fig Private Sector Market Forecast and CAGR 2020-2025 (Million USD)

Fig Private Sector Market Forecast and CAGR 2020-2025 (Volume)

• 4.3 Others
  • 4.3.1 Overview

Tab Summary of Consumption Distribution of Others

• 4.3.2 Others Market Size and Forecast

Fig Others Market Size and CAGR 2015-2019 (Million USD)

Fig Others Market Size and CAGR 2015-2019 (Volume)

Fig Others Market Forecast and CAGR 2020-2025 (Million USD)

Fig Others Market Forecast and CAGR 2020-2025 (Volume)

5 Market by Type

• 5.1 Hepatitis B Immunoglobulins
  • 5.1.1 Overview

Tab Product Overview of Hepatitis B Immunoglobulins

• 5.1.2 Hepatitis B Immunoglobulins Market Size and Forecast

Fig Hepatitis B Immunoglobulins Market Size and CAGR 2015-2019 (Million USD)

Fig Hepatitis B Immunoglobulins Market Size and CAGR 2015-2019 (Volume)

Fig Hepatitis B Immunoglobulins Market Forecast and CAGR 2020-2025 (Million USD)

Fig Hepatitis B Immunoglobulins Market Forecast and CAGR 2020-2025 (Volume)

• 5.2 Rabies Immunoglobulins
  • 5.2.1 Overview

Tab Product Overview of Rabies Immunoglobulins

• 5.2.2 Rabies Immunoglobulins Market Size and Forecast

Fig Rabies Immunoglobulins Market Size and CAGR 2015-2019 (Million USD)

Fig Rabies Immunoglobulins Market Size and CAGR 2015-2019 (Volume)

Fig Rabies Immunoglobulins Market Forecast and CAGR 2020-2025 (Million USD)

Fig Rabies Immunoglobulins Market Forecast and CAGR 2020-2025 (Volume)

• 5.3 Tetanus Immunoglobulins
  • 5.3.1 Overview

Tab Product Overview of Tetanus Immunoglobulins

• 5.3.2 Tetanus Immunoglobulins Market Size and Forecast

Fig Tetanus Immunoglobulins Market Size and CAGR 2015-2019 (Million USD)

Fig Tetanus Immunoglobulins Market Size and CAGR 2015-2019 (Volume)

Fig Tetanus Immunoglobulins Market Forecast and CAGR 2020-2025 (Million USD)

Fig Tetanus Immunoglobulins Market Forecast and CAGR 2020-2025 (Volume)

• 5.4 Others
  • 5.4.1 Overview

Tab Product Overview of Others

• 5.4.2 Others Market Size and Forecast

Fig Others Market Size and CAGR 2015-2019 (Million USD)

Fig Others Market Size and CAGR 2015-2019 (Volume)

Fig Others Market Forecast and CAGR 2020-2025 (Million USD)

Fig Others Market Forecast and CAGR 2020-2025 (Volume)

6 Price Overview

• 6.1 Price by Manufacturers

Tab Different Products Prices List of Major Manufacturers

• 6.2 Price by End-Use

Tab Different Products Prices List of End-Use

• 6.3 Price by Type

Tab Different Products Prices List of Produt Type

7 Conclusion

Summary

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The global Hyperimmune Globulins market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
CSL Behring
Grifols 
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Major applications as follows:
Government Institutions
Private Sector
Others
Major Type as follows:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa